In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...

Analyst Divya Gangahar from Morgan Stanley maintained a Buy rating on Grab (GRAB – Research Report) and increased the price target to ...

Compact and small cars may not be as popular as SUVs, but they still serve a purpose well for many of us, here are 2024's 10 ...

Brokers are tipping these shares to rise strongly from current levels. The post Got $3,000? Buy these ASX shares in October ...

Tesla is expected to unveil its autonomous "robotaxi" on Oct. 10, with analysts expecting details about the new vehicle and other potential announcements like a lower-cost model or updates to its ...

Historically, FactSet’s adjusted operating margins have been range-bound in the low to mid-30s. However, as the firm increases scale it has recently pushed margins into the 37% to 38% range.

Toyota Motors (NYSE: TM) announced on Wednesday its plan to invest an additional $500 million in Joby Aviation Inc. (NYSE: ...

Sam Poser, Williams Trading analyst, joins CNBC to discuss why he has a buy rating on Nike while shares are down today, ...

On Tuesday, Denali Therapeutics Inc (DNLI) stock saw a decline, ending the day at $28.67 which represents a decrease of $-0.46 or -1.58% from the prior close of $29.13. The stock opened at $29.18 and ...

It’s a fascinating season for FC 25 Career Mode. EA is seeking to finally restore the mode’s glory years in FC 25 by the ...

Read here for an update on Tesla's upcoming catalysts in Oct., including the robotaxi event and Q3 release, and TSLA's ...

The best early Prime Day deals from Kindle, Shark, Ninja and iRobot. What’s actually worth shopping before Prime Big Deal ...